Tarsus Pharmaceuticals, Inc. (TARS) Revenue History
Tarsus Pharmaceuticals, Inc. (TARS) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | $57.03M |
| 2022-12-31 | $25.82M |
| 2023-12-31 | $17.45M |
| 2024-12-31 | $182.95M |
| 2025-12-31 | $451.36M |
How TARS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ATRC | AtriCure Inc. | $534.53M |
| VCYT | Veracyte Inc. | $517.14M |
| ADMA | ADMA Biologics Inc | $510.17M |
| KRYS | Krystal Biotech Inc. | $389.13M |
| MNKD | MannKind Corporation | $348.97M |
These are five companies in the same sector as TARS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Tarsus Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TARS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TARS | $70.02 | +0.80% | 1.02M |
| 3 | ||||
| 4 | ||||
| 5 |